Metabolic considerations in atrial fibrillation ― Mechanistic insights and therapeutic opportunities

Masahide Harada, Jonathan Melka, Yoshihiro Sobue, Stanley Nattel

Research output: Contribution to journalReview article

7 Citations (Scopus)

Abstract

Atrial fibrillation (AF) is the most common sustained arrhythmia in clinical practice and is associated with morbidity and mortality. Over the past 2 decades, there have been major advances in understanding AF pathophysiology, but important knowledge gaps, particularly about targetable basic mechanisms, remain. Recent metabolomic and proteomic studies have shown changes in the expression of molecules involved in metabolic pathways in human and experimental AF, indicating a role for metabolic alterations in AF pathophysiology. AF is characterized by irregular high-frequency excitation and contraction that affect atrial energy demands, circulation and oxygen supply, and change the balance between metabolic demand and supply, causing metabolic stress. Here, we review the information available about AF-induced metabolic changes and their pathophysiological contribution. We also discuss the possibilities of developing novel therapeutic strategies that act by modulating cardiac metabolic processes during AF.

Original languageEnglish
Pages (from-to)1749-1757
Number of pages9
JournalCirculation Journal
Volume81
Issue number12
DOIs
Publication statusPublished - 01-01-2017

Fingerprint

Atrial Fibrillation
Therapeutics
Physiological Stress
Metabolomics
Metabolic Networks and Pathways
Proteomics
Cardiac Arrhythmias
Oxygen
Morbidity
Mortality

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine

Cite this

Harada, Masahide ; Melka, Jonathan ; Sobue, Yoshihiro ; Nattel, Stanley. / Metabolic considerations in atrial fibrillation ― Mechanistic insights and therapeutic opportunities. In: Circulation Journal. 2017 ; Vol. 81, No. 12. pp. 1749-1757.
@article{12acdf6c71a240e4837bbecd882bae68,
title = "Metabolic considerations in atrial fibrillation ― Mechanistic insights and therapeutic opportunities",
abstract = "Atrial fibrillation (AF) is the most common sustained arrhythmia in clinical practice and is associated with morbidity and mortality. Over the past 2 decades, there have been major advances in understanding AF pathophysiology, but important knowledge gaps, particularly about targetable basic mechanisms, remain. Recent metabolomic and proteomic studies have shown changes in the expression of molecules involved in metabolic pathways in human and experimental AF, indicating a role for metabolic alterations in AF pathophysiology. AF is characterized by irregular high-frequency excitation and contraction that affect atrial energy demands, circulation and oxygen supply, and change the balance between metabolic demand and supply, causing metabolic stress. Here, we review the information available about AF-induced metabolic changes and their pathophysiological contribution. We also discuss the possibilities of developing novel therapeutic strategies that act by modulating cardiac metabolic processes during AF.",
author = "Masahide Harada and Jonathan Melka and Yoshihiro Sobue and Stanley Nattel",
year = "2017",
month = "1",
day = "1",
doi = "10.1253/circj.CJ-17-1058",
language = "English",
volume = "81",
pages = "1749--1757",
journal = "Circulation Journal",
issn = "1346-9843",
publisher = "Japanese Circulation Society",
number = "12",

}

Metabolic considerations in atrial fibrillation ― Mechanistic insights and therapeutic opportunities. / Harada, Masahide; Melka, Jonathan; Sobue, Yoshihiro; Nattel, Stanley.

In: Circulation Journal, Vol. 81, No. 12, 01.01.2017, p. 1749-1757.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Metabolic considerations in atrial fibrillation ― Mechanistic insights and therapeutic opportunities

AU - Harada, Masahide

AU - Melka, Jonathan

AU - Sobue, Yoshihiro

AU - Nattel, Stanley

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Atrial fibrillation (AF) is the most common sustained arrhythmia in clinical practice and is associated with morbidity and mortality. Over the past 2 decades, there have been major advances in understanding AF pathophysiology, but important knowledge gaps, particularly about targetable basic mechanisms, remain. Recent metabolomic and proteomic studies have shown changes in the expression of molecules involved in metabolic pathways in human and experimental AF, indicating a role for metabolic alterations in AF pathophysiology. AF is characterized by irregular high-frequency excitation and contraction that affect atrial energy demands, circulation and oxygen supply, and change the balance between metabolic demand and supply, causing metabolic stress. Here, we review the information available about AF-induced metabolic changes and their pathophysiological contribution. We also discuss the possibilities of developing novel therapeutic strategies that act by modulating cardiac metabolic processes during AF.

AB - Atrial fibrillation (AF) is the most common sustained arrhythmia in clinical practice and is associated with morbidity and mortality. Over the past 2 decades, there have been major advances in understanding AF pathophysiology, but important knowledge gaps, particularly about targetable basic mechanisms, remain. Recent metabolomic and proteomic studies have shown changes in the expression of molecules involved in metabolic pathways in human and experimental AF, indicating a role for metabolic alterations in AF pathophysiology. AF is characterized by irregular high-frequency excitation and contraction that affect atrial energy demands, circulation and oxygen supply, and change the balance between metabolic demand and supply, causing metabolic stress. Here, we review the information available about AF-induced metabolic changes and their pathophysiological contribution. We also discuss the possibilities of developing novel therapeutic strategies that act by modulating cardiac metabolic processes during AF.

UR - http://www.scopus.com/inward/record.url?scp=85035211507&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85035211507&partnerID=8YFLogxK

U2 - 10.1253/circj.CJ-17-1058

DO - 10.1253/circj.CJ-17-1058

M3 - Review article

C2 - 29070758

AN - SCOPUS:85035211507

VL - 81

SP - 1749

EP - 1757

JO - Circulation Journal

JF - Circulation Journal

SN - 1346-9843

IS - 12

ER -